BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28337865)

  • 1. Helicobacter pylori and Barrett’s esophagus: a protective factor or a real cause?
    Tomasello G; Giordano F; Mazzola M; Jurjus R; Jurjus A; Damiani P; Nobile S; Carini F; Leone A
    J Biol Regul Homeost Agents; 2017; 31(1):9-15. PubMed ID: 28337865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
    World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastro-oesophageal reflux and Helicobacter pylori.
    Pace F; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases-An endoscopy cross-sectional study.
    Chuang YS; Wu MC; Wang YK; Chen YH; Kuo CH; Wu DC; Wu MT; Wu IC
    Kaohsiung J Med Sci; 2019 Jun; 35(6):341-349. PubMed ID: 31001924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
    Liu FX; Wang WH; Wang J; Li J; Gao PP
    Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable?
    Vicari J; Falk GW; Richter JE
    Am J Gastroenterol; 1997 Jul; 92(7):1097-102. PubMed ID: 9219777
    [No Abstract]   [Full Text] [Related]  

  • 8. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
    Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection and the risk of adenocarcinoma of the esophagus.
    Celiński K; Słomka M; Kasztelan-Szczerbińska B; Madro A; Cichoz-Lach H; Kurzeja A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):424-7. PubMed ID: 16146024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and gastroesophageal reflux disease.
    Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2014 Jul; 30(4):402-7. PubMed ID: 24848647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.
    Kountouras J; Doulberis M; Papaefthymiou A; Polyzos SA; Vardaka E; Tzivras D; Dardiotis E; Deretzi G; Giartza-Taxidou E; Grigoriadis S; Katsinelos P
    Ann N Y Acad Sci; 2019 Sep; 1452(1):12-17. PubMed ID: 31310338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of gastroesophageal reflux and Barrett esophagus].
    von Schrenck T
    Zentralbl Chir; 2000; 125(5):414-23. PubMed ID: 10929625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori: a debated factor in gastroesophageal reflux disease.
    Sharma P
    Dig Dis; 2001; 19(2):127-33. PubMed ID: 11549822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
    Kountouras J; Chatzopoulos D; Zavos C
    Med Hypotheses; 2007; 68(5):1174-5. PubMed ID: 17196756
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for esophageal cancer: emphasis on infectious agents.
    El-Zimaity H; Di Pilato V; Novella Ringressi M; Brcic I; Rajendra S; Langer R; Dislich B; Tripathi M; Guindi M; Riddell R
    Ann N Y Acad Sci; 2018 Dec; 1434(1):319-332. PubMed ID: 29851130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
    Clark GW
    World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histologic squamo-oxyntic gap: an accurate and reproducible diagnostic marker of gastroesophageal reflux disease.
    Chandrasoma P; Wijetunge S; Demeester SR; Hagen J; Demeester TR
    Am J Surg Pathol; 2010 Nov; 34(11):1574-81. PubMed ID: 20871393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between Helicobacter pylori and gastroesophageal reflux disease.
    Bowrey DJ; Williams GT; Clark GW
    Dis Esophagus; 1998 Oct; 11(4):203-9. PubMed ID: 10071799
    [No Abstract]   [Full Text] [Related]  

  • 19. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: Helicobacter pylori and reflux disease.
    Sharma P; Vakil N
    Aliment Pharmacol Ther; 2003 Feb; 17(3):297-305. PubMed ID: 12562442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.